Paul Lin - Concepedia

Author

Paul Lin

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

P Lin, P. Lin, P. Y. Lin, PAUL LIN, PAUL Y LIN, Paul Lin, Paul Y Lin, Paul Y. Lin, Paul Yang Lin, Paul- Yang Lin

110

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Chiayi Chang Gung Memorial Hospital Chang Gung University Chang Gung Memorial Hospital Case Western Reserve University

About

Paul Lin is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	845
2	Cell Biology	10	10	681
3	Health Sciences	3	3	148
4	Natural Sciences	2	2	39
5	Biochemistry	1	1	21

Paul Lin

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation Thomas J. Kean, Paul Lin, Arnold I. Caplan, Stem Cells International	2013	441
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial David Marín, Ye Li, Rafet Başar, Nature Medicine	2024	376
Assessing Porcine Liver-Derived Biomatrix for Hepatic Tissue Engineering Paul Lin, Warren C. W. Chan, Stephen F. Badylak, Tissue Engineering	2004	239
Endoscopic submucosal dissection for the treatment of intraluminal gastric subepithelial tumors originating from the muscularis propria layer I.-L. Lee, Paul Lin, Shui‐Yi Tung, Endoscopy	2006	185
Targeting Improves MSC Treatment of Inflammatory Bowel Disease In Kap Ko, Byung‐Gyu Kim, Amad Awadallah, Molecular Therapy	2010	175
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape Ye Li, Rafet Başar, Guohui Wang, Nature Medicine Natural Killer CellsImmunologyTumor EscapeCell DeathImmune Checkpoint Inhibitor	2022	152
IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus Miao-Fen Chen, Ping-Tsung Chen, Ming Lu, Molecular Cancer	2013	151
Sequential exposure to fibroblast growth factors (FGF) 2, 9 and 18 enhances hMSC chondrogenic differentiation Diego Correa, Rodrigo A. Somoza, Paul Lin, Osteoarthritis and Cartilage Regenerative MedicineDevelopmental BiologySequential ExposureCartilage DegenerationGynecology	2014	128
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering Li Li, Vakul Mohanty, Jinzhuang Dou, Science Advances ImmunologyNk CellsCar-nk Cell TherapyImmunologic MechanismMetabolic Remodeling	2023	94
Efficient Lentiviral Transduction of Human Mesenchymal Stem Cells That Preserves Proliferation and Differentiation Capabilities Paul Lin, Yuan Lin, Donald P. Lennon, Stem Cells Translational Medicine	2012	84

Page 1